RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$7.38
+0.17 (+2.36%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+450.9% upside
Low Target
$22.44
Average Target
$40.66
High Target
$45.57
Current Price
$7.38
Current
$7.38
$7.38
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Scenario Analysis
Bear Case
$22.44
204.1%
Low target
Base Case
$40.66
+450.9%
Avg target
Bull Case
$45.57
+517.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$11.00
-32.9% from high
52-Week Low
$5.60
+31.8% from low
Target vs 52W High
$40.66
+269.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.2% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.9% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +139.7% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.8% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -26.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.5% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.2% |